e-learning
resources
Vienna 2003
Sunday 28.09.2003
Clinical aspects and consequences of sleep related breathing disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The state and responsiveness of the renin-angiotensin-aldosterone system in obstructive sleep apnoea
Y. Peker, L. Grote, G. Johannsson, J. Hedner (Gothenburg, Sweden)
Source:
Annual Congress 2003 - Clinical aspects and consequences of sleep related breathing disorders
Session:
Clinical aspects and consequences of sleep related breathing disorders
Session type:
Thematic Poster Session
Number:
652
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Peker, L. Grote, G. Johannsson, J. Hedner (Gothenburg, Sweden). The state and responsiveness of the renin-angiotensin-aldosterone system in obstructive sleep apnoea. Eur Respir J 2003; 22: Suppl. 45, 652
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 294s
Year: 2006
Comparisson of corrective effects of APAP and CPAP on disordered autonomic nervous system function in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007
Autonomic changes during obstructive and central apneas in patients with sleep apnea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
ACE-inhibitors and obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 358s
Year: 2005
Treatment of obstructive and central sleep apnoea in heart failure: practical options
Source: Eur Respir Rev 2007; 16: 183-188
Year: 2007
The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005
Catecholamine secretion in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
The relation between obstructive apneas in OSA patients and autonomic activity
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
The velumount device for obstructive sleep apnoea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Influence of treatment on leptin levels in patients with obstructive sleep apnoea
Source: Eur Respir J 2004; 23: 601-604
Year: 2004
The metabolic consequences of obstructive sleep apnoea in children
Source: Breathe 2009; 6: 111-114
Year: 2009
Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive airway pressure treatment
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008
Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept